Related Experiment Video
Updated: May 8, 2026
12:19
Tools to Study the Role of Architectural Protein HMGB1 in the Processing of Helix Distorting, Site-specific DNA Interstrand Crosslinks
Published on: November 10, 2016
From old alkylating agents to new minor groove binders
Stéphane Puyo1, Danièle Montaudon1, Philippe Pourquier1
1INSERM U916, Institut Bergonié, 229 cours de l'Argonne, 33076 Bordeaux cedex, France.
Critical Reviews in Oncology/Hematology
|August 27, 2013
Summary
Alkylating agents, a foundational cancer treatment, remain vital for refractory tumors. Newer DNA minor groove-targeting agents show promise for combination therapies to improve cancer treatment outcomes.
Area of Science:
- Oncology
- Medicinal Chemistry
- Molecular Biology
Background:
- Alkylating agents are the oldest class of anticancer drugs, with a history dating back to the FDA approval of mechloretamine in 1949.
- Despite the advent of targeted therapies, alkylating agents remain crucial in treating specific malignancies and are often the sole option for refractory tumors.
Purpose of the Study:
- To review the major classes of alkylating agents, emphasizing recent advancements.
- To highlight novel compounds targeting the DNA minor groove and their unique mechanisms of action.
- To discuss the renewed interest in developing new alkylating agents for combination cancer therapy.
Main Methods:
- Literature review of major alkylating agent classes.
- Focus on recent generations of compounds targeting the DNA minor groove.
- Analysis of mechanisms of action and potential for combination therapies.
Main Results:
- Alkylating agents continue to play a significant role in cancer treatment, particularly for resistant tumors.
- Newer alkylating agents specifically designed to interact with the DNA minor groove are under development.
- These agents possess unique mechanisms that have revitalized interest in their therapeutic potential.
Conclusions:
- Alkylating agents, including novel DNA minor groove binders, are essential in modern oncology.
- The unique action of these compounds supports their investigation in combination regimens to enhance antitumor efficacy.
- Further research into new alkylating agents could lead to improved treatment strategies for various cancers.
More Related Videos
Related Concept Videos
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
01:10Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
02:27Preparation of Alkynes: Alkylation Reaction
Introduction
Alkylation of terminal alkynes with primary alkyl halides in the presence of a strong base like sodium amide is one of the common methods for the synthesis of longer carbon-chain alkynes. For example, treatment of 1-propyne with sodium amide followed by reaction with ethyl bromide yields 2-pentyne.
Alkylation of terminal alkynes with primary alkyl halides in the presence of a strong base like sodium amide is one of the common methods for the synthesis of longer carbon-chain alkynes. For example, treatment of 1-propyne with sodium amide followed by reaction with ethyl bromide yields 2-pentyne.
01:05Maxam-Gilbert Sequencing
In the same year as the discovery of the Sanger sequencing method, another group of scientists, Allan Maxam and Walter Gilbert, demonstrated their chemical-cleavage method for DNA sequencing. The Maxam-Gilbert method relies on using different chemicals that can cleave the DNA sequence at specific sites, the separation of resulting DNA fragments of variable size using electrophoresis, and deciphering the DNA sequence from the resulting gel bands.
Challenges of the Maxam-Gilbert Method
The...
Challenges of the Maxam-Gilbert Method
The...
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
01:30Spontaneous and Induced Mutations
Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).